01/22/2025 | Press release | Distributed by Public on 01/22/2025 14:41
The human immune system is like an army of specialized soldiers (immune cells) each with a unique role to play in fighting disease. In a new study published in Nature led by scientists at the University of California San Diego (School of Biological Sciences and School of Medicine), the Allen Institute and La Jolla Institute for Immunology, researchers reveal how cells known as tissue-resident memory CD8 T cells play unique and specialized roles based on where they are located within the small intestine. Tissue-resident memory cells provide a local first line of defense against re-infection and call for "backup" from other immune cells and are also critical for maintaining peace in a tissue exposed to many outside pathogens.
This discovery sheds light on how tissue-resident memory CD8 T cells adapt to their location in the body, ensuring a coordinated and effective immune response and how microenvironments and cellular interactions shape this location-specific adaptation. Ultimately, location matters, and this understanding could also lead to improved immunotherapy and vaccines.
The study shows that tissue-resident memory CD8 T cells in the small intestine are diverse with distinct responsibilities, and their position inside the gut's architecture dictates what they do.
"What really struck me is that we have been able to see that immune cells in distinct locations have these special functions," said Maximilian Heeg, M.D., one of the study's lead co-authors and investigator at the Allen Institute. "They're strategically positioned in the small intestine to fulfill their function, and this is the key finding from the paper."
These differences ensure the immune system can react quickly to immediate threats while simultaneously maintaining a backup defense for long-term protection.
"In response to infection, immune cells stream into tissues to fight infection and help repair damage. Importantly, these cells 'talk to' the tissue cells to coordinate the immune response," said UC San Diego School of Biological Sciences Professor Ananda Goldrath, who serves as executive vice president of the Allen Institute for Immunology. "In this study, we can now visualize how the functional state of an immune cell relates to which cells and signals are found in different neighborhoods or regions of the tissues. This new knowledge of how the immune system works in tissues is game changing as we explore how to enhance immune protection while avoiding damaging inflammation."
Using advanced transcriptional profiling techniques, the researchers mapped the genetic instructions that instruct the behavior of tissue-resident memory CD8 T cells based on their location. "I am most excited about the possibilities our new approaches bring: Studying immune cells in their unperturbed natural environments at high plex, throughput and resolution," said Miguel Reina-Campos, study co-author, former UC San Diego postdoctoral scholar and assistant professor at the La Jolla Institute for Immunology.
The findings provide insight for designing better immunotherapies and vaccines. By targeting the mechanisms that direct tissue-resident memory CD8 T cells to specific sites inside a tissue and enhance their capabilities, researchers hope to develop treatments to boost the immune system's effectiveness and keep us healthy.
"One part of this work was discovering causal relationships between well-characterized genes and CD8 T cell spatial and transcriptional phenotypes," said study co-first author Alex Monell, a UC San Diego graduate student working with Goldrath. "We are expanding our CRISPR-pooled spatial screening to profile the impacts of many types of genetic perturbations at once within CD8 T cells with an overarching goal of finding and manipulating modulatory mechanisms of tissue-specific immunity."
This work highlights the importance of anatomical niches in shaping immune responses and establishes a framework for studying how immune cells interact with their environment. It presents new approaches in treating chronic diseases, infections and inflammatory disorders by leveraging the unique dynamics of tissue-resident memory immune cells in barrier tissues.
Moving forward, the group is focused on understanding how this knowledge can be used to therapeutically target our immune responses.
Additional authors of the study include Amir Ferry, Vida Luna, Kitty Cheung, Giovanni Galletti, Nicole Scharping, Kennidy Takehara, Sara Quon, Peter Challita, Brigid Boland, Yun Hsuan Lin, William Wong, Cynthia Indralingam, Hayley Neadeau, Suzie Alarcón, Gene Yeo and John Chang.
The research was funded by the National Institutes of Health (grants R01AI179952, R37AI067545, P01AI132122, R01AI072117, R01AI150282, R01CA273432, S10OD025052, and F31AI176705), NIDDK-funded San Diego Digestive Diseases Research Center (P30DK120515), U.S. Department of Veterans Affairs CRSD Service (I01 CX002396), NINDS (P30NS047101), a NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award (K00CA222711), a Canadian Institutes of Health Research Doctoral Foreign Study Award, and a Cancer Research Institute Postdoctoral Fellowship (CRI4145).
Competing interest disclosures: Reina-Campos is a co-founder, scientific adviser and board member of TCura Bioscience Inc. Ferry is a co-founder, CEO and board member of TCura Bioscience. Boland receives consulting fees from Bristol Myers Squibb and Pfizer and research grants from Merck and Gilead. Goldrath is a co-founder of TCura Bioscience, Inc. and serves on the scientific advisory board of ArsenalBio and Foundery Innovations.
- Adapted from an Allen Institute release